08 December,2024 06:05 PM IST | Warsaw (Poland) | IANS
Iga Swiatek. Pic/AFP
Five-time Grand Slam champion Iga Swiatek described her recent doping suspension as a "horror and nightmare" while emphasizing her determination to prove her innocence. Swiatek, 23, tested positive for trace amounts of Trimetazidine (TMZ) in an out-of-competition sample taken on August 12.
The International Tennis Integrity Agency (ITIA) announced on November 28 that the violation was unintentional, attributing the positive test to contamination in a regulated melatonin product she used for jet lag and sleep issues. Swiatek accepted a one-month suspension, retroactively served, allowing her to compete again by December 4, reports Xinhua.
"My reaction was very intense - confusion, panic, a lot of crying," Swiatek told Polish media. "It felt like something terrible had happened to my health or career."
Also Read: "Rohit Sharma plays like he's relaxing with a cup of coffee": Hayden
ALSO READ
Dope case: Halep points to leniency towards No. 2 Swiatek
After Jannik, Iga turns out to be a ‘sinner’ too!
Five-time Grand Slam champion Iga Swiatek accepts a one-month suspension in doping case
From Novak Djokovic to Iga Swiatek, players reflect on Rafael Nadal''s career and retirement
Italy eliminate Swiatek’s Poland to reach final
The Pole revealed she spent significant resources -- $70,000 on legal fees and â¬15,000 on expert tests -- to clear her name. "The most important thing was to prove my innocence," she said. Swiatek expressed relief that the ordeal ended swiftly. "I can start the new season with a clean slate and focus on playing," she concluded.
The ITIA has accepted that the prohibited substance was because of a contaminated regulated medication, which results in a "No Significant Fault or Negligence finding", thus handing a one-month suspension.
"The International Tennis Integrity Agency (ITIA) today confirms that Iga Swiatek, a 23-year-old tennis player from Poland, has accepted a one-month suspension under the Tennis Anti-Doping Programme, after testing positive for the prohibited substance trimetazidine (TMZ) in an out-of-competition sample in August 2024," the ITIA informed.
An investigation by ITIA has determined that the source for the presence of the banned substance was a "contaminated regulated medication". The ITIA probe said the test "results in no significant fault or negligence finding and thus handed a one-month suspension", the statement said.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever